School scientists recently uncovered how neurons normally recycle old proteins, and how this process goes awry in Alzheimer's disease, leading to the toxic building of protein fragments in the brain.
USAID’s “Stronger There, Safer Here” exhibit is on display June 12 to July 31, 2019, on the first floor of Mission Hall at UCSF’s Mission Bay campus.
A photo exhibition on the response by the United States Agency for International Development (USAID) to Zika virus outbreaks in Latin America and the Caribbean was kicked off with a reception this June at the UC San Francisco Mission Bay campus.
Research on topics ranging from drug abuse to heart pump complications took top honors at the Department of Clinical Pharmacy’s 21st annual Spring Research Seminar.
Mary Anne Koda-Kimble, PharmD, former dean of the School of Pharmacy
The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.
A team led by Pamela England, PhD, identified a new target (yellow) for future Parkinson’s disease therapies within the Nurr1 protein (blue).
Scientists in the UCSF School of Pharmacy recently identified the first drug-binding target site on a molecule known to play a role in Parkinson's disease, opening the door to a new generation of therapies for the condition.
Deanna Kroetz, PhD (right) was among dozens of faculty members who contributed to the School of Pharmacy becoming the top recipient of NIH funding among all pharmacy schools in 2018.
Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences.
